710
Views
0
CrossRef citations to date
0
Altmetric
Critical Care Nephrology and Continuous Kidney Replacement Therapy

Assessment of urine CCL2 as a potential diagnostic biomarker for acute kidney injury and septic acute kidney injury in intensive care unit patients

, , , &
Article: 2313171 | Received 28 Jul 2023, Accepted 27 Jan 2024, Published online: 12 Feb 2024

References

  • Kellum JA, Romagnani P, Ashuntantang G, et al. Acute kidney injury. Nat Rev Dis Primers. 2021;7(1):1. doi: 10.1038/s41572-021-00284-z.
  • Case J, Khan S, Khalid R, et al. Epidemiology of acute kidney injury in the intensive care unit. Crit Care Res Pract. 2013;2013:479730–9. doi: 10.1155/2013/479730.
  • Wan L, Bagshaw SM, Langenberg C, et al. Pathophysiology of septic acute kidney injury: what do we really know? Crit Care Med. 2008;36(4):S198–S203. doi: 10.1097/CCM.0b013e318168ccd5.
  • Ostermann M, Bellomo R, Burdmann EA, et al. Controversies in acute kidney injury: conclusions from a kidney disease: improving global outcomes (KDIGO) conference. Kidney Int. 2020;98(2):294–309. doi: 10.1016/j.kint.2020.04.020.
  • Moledina DG, Parikh CR. Phenotyping of acute kidney injury: beyond serum creatinine. Semin Nephrol. 2018;38(1):3–11. doi: 10.1016/j.semnephrol.2017.09.002.
  • Delanaye P, Cavalier E, Stehlé T, et al. Serum creatinine: not so simple. Nephron. 2017;136(4):302–308. doi: 10.1159/000536243.
  • Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365(9466):1231–1238. doi: 10.1016/S0140-6736(05)74811-X.
  • Bagshaw SM, Darmon M, Ostermann M, et al. Current state of the art for renal replacement therapy in critically ill patients with acute kidney injury. Intensive Care Med. 2017;43(6):841–854. doi: 10.1007/s00134-017-4762-8.
  • Liu H, Hou S, Tian X. Risk factors of sepsis associated acute kidney injury in patients with sepsis: a meta-analysis. Intensive Care Res. 2023;3:1–8.
  • Athavale AM, Fu C-Y, Bokhari F, et al. Incidence of, risk factors for, and mortality associated with severe acute kidney injury after gunshot wound. JAMA Netw Open. 2019;2(12):e1917254-e1917254. doi: 10.1001/jamanetworkopen.2019.17254.
  • Jing J, Gao Y. Urine biomarkers in the early stages of diseases: current status and perspective. Discov Med. 2018;25(136):57–65.
  • Cerri C, Genovesi S, Allegra M, et al. The chemokine CCL2 mediates the seizure-enhancing effects of systemic inflammation. J Neurosci. 2016;36(13):3777–3788. doi: 10.1523/JNEUROSCI.0451-15.2016.
  • Maus UA, Waelsch K, Kuziel WA, et al. Monocytes are potent facilitators of alveolar neutrophil emigration during lung inflammation: role of the CCL2-CCR2 axis. J Immunol. 2003;170(6):3273–3278. doi: 10.4049/jimmunol.170.6.3273.
  • Jia P, Xu S, Wang X, et al. Chemokine CCL2 from proximal tubular epithelial cells contributes to sepsis-induced acute kidney injury. Am J Physiol Renal Physiol. 2022;323(2):F107–F119. doi: 10.1152/ajprenal.00037.2022.
  • Kellum JA, Lameire N, Aspelin P, et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1–138.
  • Pickering JW, Endre ZH. Back-calculating baseline creatinine with MDRD misclassifies acute kidney injury in the intensive care unit. Clin J Am Soc Nephrol. 2010;5(7):1165–1173. doi: 10.2215/CJN.08531109.
  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810. doi: 10.1001/jama.2016.0287.
  • Gniewkiewicz MS, Czerwińska M, Gozdowska J, et al. Urinary levels of CCL2 and CXCL10 chemokines as potential biomarkers of ongoing pathological processes in kidney allograft: an association with BK virus nephropathy. Pol Arch Intern Med. 2019;129(9):592–597. doi: 10.20452/pamw.14926.
  • Pinheiro KHE, Azêdo FA, Areco KCN, et al. Risk factors and mortality in patients with sepsis, septic and non septic acute kidney injury in ICU. J Bras Nefrol. 2019;41(4):462–471. doi: 10.1590/2175-8239-JBN-2018-0240.
  • Samsu N, Marzuki MJ, Pratiwi IC, et al. Predictors in-hospital mortality of septic vs non-septic acute kidney injury patients: an observational cohort study. F1000Res. 2022;10:1184. doi: 10.12688/f1000research.74540.2.
  • Westenfelder C. Earlier diagnosis of acute kidney injury awaits effective therapy. Kidney Int. 2011;79(11):1159–1161. doi: 10.1038/ki.2011.19.
  • Dobilienė D, Masalskienė J, Rudaitis Š, et al. Early diagnosis and prognostic value of acute kidney injury in critically ill patients. Medicina. 2019;55(8):506. doi: 10.3390/medicina55080506.
  • Abarca Rozas B, Mestas Rodríguez M, Widerström Isea J, et al. A current view on the early diagnosis and treatment of acute kidney failure. Medwave. 2020;20(5):e7928–e7928. doi: 10.5867/medwave.2020.05.7928.
  • Bossink AW, Paemen L, Jansen PM, et al. Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood. 1995;86(10):3841–3847. doi: 10.1182/blood.V86.10.3841.bloodjournal86103841.
  • He J, Chen Y, Lin Y, et al. Association study of MCP-1 promoter polymorphisms with the susceptibility and progression of sepsis. PLoS One. 2017;12(5):e0176781. doi: 10.1371/journal.pone.0176781.
  • Wang Y, Liu Q, Liu T, et al. Early plasma monocyte chemoattractant protein 1 predicts the development of sepsis in trauma patients: a prospective observational study. Medicine (Baltimore). 2018;97(14):e0356. doi: 10.1097/MD.0000000000010356.
  • Hüsing AM, Wulfmeyer VC, Gaedcke S, et al. Myeloid CCR2 promotes atherosclerosis after AKI. J Am Soc Nephrol. 2022;33(8):1487–1500. doi: 10.1681/ASN.2022010048.
  • Leon LR, Blaha MD, DuBose DA. Time course of cytokine, corticosterone, and tissue injury responses in mice during heat strain recovery. J Appl Physiol (1985). 2006;100(4):1400–1409. doi: 10.1152/japplphysiol.01040.2005.
  • Song P, Li W, Xie J, et al. Cytokine storm induced by SARS-CoV-2. Clin Chim Acta. 2020;509:280–287. doi: 10.1016/j.cca.2020.06.017.
  • Tweedie D, Karnati HK, Mullins R, et al. Time-dependent cytokine and chemokine changes in mouse cerebral cortex following a mild traumatic brain injury. Elife. 2020;9:e55827. doi: 10.7554/eLife.55827.
  • Al-Saegh RM, Mohanad M, Khudhair NJ, et al. Using urinary interleukin-18 as a potential marker for early detection of acute kidney injury in intensive care unit. Saudi J Kidney Dis Transpl. 2021;32(2):341–347. doi: 10.4103/1319-2442.335445.
  • Liu P, Li X, Lv W, et al. Inhibition of CXCL1-CXCR2 axis ameliorates cisplatin-induced acute kidney injury by mediating inflammatory response. Biomed Pharmacother. 2020;122:109693. doi: 10.1016/j.biopha.2019.109693.
  • Nagarjun Batchu S, Ganesh Yerra V, Hong Y, et al. 397-P: epigenetic regulation of the chemokine CXCL2 in acute kidney injury in diabetes. Diabetes. 2023;72(1):397. doi: 10.2337/db23-397-P.
  • Ma K, Meng Y, Zheng Z. WCN23-1031 CCL5 blockade reduces leukocyte accumulation and renal tubule injury in obese mice with acute kidney injury. Kidney Int Rep. 2023;8(3):S37–S38. doi: 10.1016/j.ekir.2023.02.085.